Rare Biomarkers Specimen Collection and Stabilization

Rare Biomarkers Specimen Collection and StabilizationGlobal Rare Biomarkers Specimen Collection and Stabilization Market to Reach $78.6 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Rare Biomarkers Specimen Collection and Stabilization estimated at US$31.6 Billion in the year 2022, is projected to reach a revised size of US$78.6 Billion by 2030, growing at aCAGR of 12.1% over the period 2022-2030. Circulating Cell Free DNA (ccfDNA), one of the segments analyzed in the report, is projected to record 11.2% CAGR and reach US$30.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Circulating Tumor Cells (CTCs) segment is readjusted to a revised 12.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $9.4 Billion, While China is Forecast to Grow at 11.2% CAGR
The Rare Biomarkers Specimen Collection and Stabilization market in the U.S. is estimated at US$9.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$13.3 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.1% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.Select Competitors (Total 32 Featured) - Advanced Cell Diagnostics, Inc.Agena BioscienceANGLE plcApoCell, Inc.AS One InternationalNTERNATIONALBioChain Institute, Inc.Biolidics LimitedBiomatricaBio-Techne CorporationBioVision, Inc.Caltag Medsystems LimitedCytomark Ltd.DNA Genotek, Inc.Epic SciencesEpiGentek Group Inc.F. Hoffmann-La Roche LtdFluxion Biosciences, Inc.Geno Technology Inc.Genomax Technologies Pte Ltd.GILUPI GmbHLifeSpan BioSciences, Inc.MagBio Genomics Inc.Menarini Silicon BiosystemsMyBioSource.comNorgen Biotek Corp.Novus Biologicals, LLCOraSure Technologies Inc.Precision for Medicine, Inc.Promega CorporationQIAGENRarecells Diagnostics SASRareCyte, Inc.siemens HealthineersSiO2 Materials ScienceSTEMCELL Technologies Inc.Streck, Inc.Thermo Fisher Scientific, Inc.Vortex BiosciencesVyCAP B.V.Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.